Rhinitis and sleep

Sleep Medicine Reviews

Volumn 15, Issue 5, 2011, Pages 293-299

  Lunn, Michael ^a   Craig, Timothy ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Allergic rhinitis; Chronic rhinitis; Intranasal corticosteroid; Sleep apnea; Sleep disturbance

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BUDESONIDE; CORTICOSTEROID; DECONGESTIVE AGENT; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

ALLERGIC RHINITIS; DAYTIME SOMNOLENCE; FATIGUE; HUMAN; INSOMNIA; NOSE CONGESTION; PREVALENCE; QUALITY OF LIFE; REM SLEEP; REVIEW; RHINOMANOMETRY; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SOMNOLENCE; TACHYCARDIA; URINE RETENTION;

ADULT; CHILD; FEMALE; HUMANS; MALE; QUALITY OF LIFE; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; SLEEP; SLEEP APNEA SYNDROMES;

EID: 80051597315     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2010.12.001     Document Type: Review

References (106)

1. Bachert C., van Cauwenberge P., Khaltaev N. Allergic Rhinitis and its Impact on Asthma (ARIA). In collaboration with the World Health Organization. Executive summary of the workshop report. December 7-10, 1999; Geneva, Switzerland. Allergy 2002, 57:841-855.
2. Salib R.J., Drake-Lee A., Howarth P.H. Allergic rhinitis: past, present and the future. Clin Otolaryngol 2003, 28:291-303.
3. Dykewicz M.S., Fineman S., Skoner D.P., Nicklas R., Lee R., Blessing-Moore J., et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998, 81:478-518.
4. Bauchau V., Durham S.R. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004, 24:758-764.
5. D'Alonzo G.E. Scope and impact of allergic rhinitis. J Am Osteopath Assoc 2002, 102:S2-S6.
6. Derebery J., Meltzer E., Nathan R.A., Stang P.E., Campbell U.B., Corrao M., et al. Rhinitis symptoms and comorbidities in the United States: burden of rhinitis in America survey. Otolaryngol - Head Neck Surg 2008 Aug, 139(2):198-205.
7. Suratt P.M., Turner B.L., Wilhoit S.C. Effect of intranasal obstruction on breathing during sleep. Chest 1986, 90:324-329.
8. Millman R.P., Acebo C., Rosenberg C., Carskadon M.A. Sleep, breathing, and cephalometrics in older children and young adults. Part II - response to nasal occlusion. Chest 1996, 109:673-679.
9. Young T., Finn L., Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med 2001, 161:1514-1519.
10. Rappai M., Collop N., Kemp S. The nose and sleep-disordered breathing. What we know and what we do not know. Chest 2003, 124:2309-2323.
11. Meltzer E.O., Blaiss M.S., Derebery M.J., Mahr T.A., Gordon B.R., Sheth K.K., et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009 Sep, 124(3 Suppl):S43-S70.
12. Meltzer E.O., Nathan R., Derebery J., Stang P.E., Campbell U.B., Yeh W.S., et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009 May-Jun, 30(3):244-254.
13. Blaiss M., Reigel T., Philpot E. A study to determine the impact of rhinitis on sufferers' sleep and daily routine. J Allergy Clin Immunol 2005, 115:S197. [abstract].
14. Stempel D.A., Woolf R. The cost of treating allergic rhinitis. Curr Allergy Asthma Rep 2002, 2:223-230.
15. Leynaert B., Neukirch C., Liard R. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000, 162:1391-1396.
16. Bousquet J., Bullinger M., Fayol C., Marquis P., Valentin B., Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994, 94:182-188.
17. Juniper E. Quality of life in adults and children with asthma and rhinitis. Allergy 1997, 52:971-977.
18. Blaiss M.S. Quality of life in allergic rhinitis. Ann Allergy Asthma Immunol 1999, 83:449-454.
19. Thompson A.K., Juniper E., Meltzer E.O. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000, 85:338-348.
20. Meltzer E.O. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001, 108:S45-S53.
21. Majani G., Baiardini I., Giardini A., Senna G.E., Minale P., D'Ulisse S., et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001, 56:313-317.
22. Stull D.E., Roberts L., Frank L., Heithoff K. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin 2007 Apr, 23(4):811-819.
23. Ferguson B.J. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 2004, 130:617-629.
24. American Academy of Allergy Asthma and Immunology. The Allergy report Available at:, [accessed 20.04.06]. http://www.theallergyreport.com/reportindex.html.
25. McNicholas W.T., Tarlo S., Cole P., Zamel N., Rutherford R., Griffin D., et al. Obstructive sleep apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982, 126:625-628.
26. Staevska M.T., Mandajieva M.A., Dimitrov V.D. Rhinitis and sleep apnea. Curr Allergy Asthma Rep 2004, 4:193-199.
27. Lavie P., Gertner R., Zomer J., Podoshin L. Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis. Acta Otolaryngol 1981, 92:529-533.
28. Kramer M.F., De La Chaux R., Derher A., Pfrogner E., Rasp G. Allergic rhinitis does not constitute a risk factor for obstructive sleep apnea syndrome. Acta Otolaryngol 2001, 121:494-499.
29. Young T., Finn L., Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol 1997, 99:S757-S762. The University of Wisconsin Sleep and Respiratory Research Group.
30. Rimmer J., Downie S., Bartlett D.J., Gralton J., Salome C. Sleep disturbance in persistent allergic rhinitis measured using actigraphy. Annals of Allergy, Asthma, & Immunology 2009 Sep, 103(3):190-194.
31. Chng S.Y., Goh D.Y., Wang X.S., Tan T.N., Ong N.B. Snoring and atopic disease: a strong association. Pediatr Pulmonol 2004, 38:210-216.
32. Sogut A., Altin R., Uzun L., et al. Prevalence of obstructive sleep apnea syndrome and associated symptoms in 3-11 year-old Turkish children. Pediatr Pulmonol 2005, 39:251-256.
33. McColley S.A., Carroll J.L., Curtis S., Loughlin G.M., Sampson H.A. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997, 111:170-173.
34. Bixler E.O., Vgontzas A.N., Lin H.M., Liao D., Calhoun S., Vela-Bueno A., et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep 2009 Jun 1, 32(6):731-736.
35. Janson C., De Backer W., Gislason T., Plaschke P., Björnsson E., Hetta J., et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J 1996, 9:2132-2138.
36. Craig T.J., McCann J.L., Gurevich F., et al. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 2004, 114:S139-S145.
37. Craig T.J., Teets S., Lehman E.B., et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998, 101:633-637.
38. Stuck B.A., Czajkowski J., Hagner A.E., Klimek L., Verse T., Hörmann K., et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004, 113:663-668.
39. Corey J.P., Houser S.M., Ng B.A. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J 2000, 79:690-693. 696, 698.
40. Jessen M., Malm L. Definition, prevalence and development of nasal obstruction. Allergy 1997, 52:3-6.
41. Nathan R.A., Eccles R., Howarth P.H., Steinsvåg S.K., Togias A. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 2005, 115:S442-S459.
42. Houser S.M., Mamikoglu B., Aquino B.F., Moinuddin R., Corey J.P. Acoustic rhinometry findings in patients with mild sleep apnea. Otolaryngol Head Neck Surg 2002, 126:475-480.
43. Mamikoglu B., Houser S.M., Corey J.P. An interpretation method for objective assessment of nasal congestion with acoustic rhinometry. Laryngoscope 2002, 112:926-929.
44. Rundcrantz H. Postural variations of nasal patency. Acta Otolaryngol 1969, 68:435-443.
45. Landstra A.M., Postma D.S., Boezen H.M., van Aalderen W.M. Role of serum cortisol levels in children with asthma. Am J Respir Crit Care Med 2002, 165:708-712.
46. Reinberg A., Gervais P., Levi F., Smolensky M., Del Cerro L., Ugolini C. Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol 1988, 81:51-62.
47. Roper Public Affairs Group of NOP World Impact of nasal congestion among allergic rhinitis sufferers. An internet survey of 2002 people May-June 2004, New York, NY.
48. Juniper E.F., Rohrbaugh T., Meltzer E.O. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003, 111:484-490.
49. Canova C.R., Downs S.H., Knoblauch A., Andersson M., Tamm M., Leuppi J.D. Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration 2004, 71:138-143.
50. Chen W., Kushida C.A. Nasal obstruction in sleep-disordered breathing. Otolaryngol Clin North Am 2003, 36:437-460.
51. Storms W.W. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 2004, 114:S146-S153.
52. Camhi S.L., Morgan W.J., Pernisco N., Quan S.F. Factors affecting sleep disturbances in children and adolescents. Sleep Med 2000, 1:117-123.
53. Pitt A.D., Smith A.F., Lindsell L., Voon L.W., Rose P.W., Bron A.J. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004 Feb, 11(1):17-33.
54. Sack R., Conradi L., Beaton A., Sathe S., McNamara N., Leonardi A. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp Eye Res 2007 Oct., 85(4):528-538.
55. Tashiro M., Mochizuki H., Iwabuchi K., Sakurada Y., Itoh M., Watanabe T., et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci 2002, 72:409-414.
56. Mullington J.M., Hinze-Selch D., Pollmacher T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci 2001, 933:201-210.
57. Krouse H.J., Davis J.E., Krouse J.H. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg 2002, 126:607-613.
58. Aoyagi M., Watanabe H., Sekine K., Nishimuta T., Konno A., Shimojo N., et al. Circadian variation in nasal reactivity in children with allergic rhinitis: correlation with the activity of eosinophils and basophilic cells. Int Arch Allergy Immunol 1999, 120:95-99.
59. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follett H., Kales A., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004 May., 89(5):2119-2126.
60. Woodson B.T., Brusky L.T., Saurajen A., Jaradeh S. Association of autonomic dysfunction and mild obstructive sleep apnea. Otolaryngol - Head Neck Surg 2004 Jun, 130(6):643-648.
61. Marshall P.S., O'Hara C., Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol 2000, 84:403-410.
62. Wilken J.A., Berkowitz R., Kane R. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol 2002, 89:372-380.
63. Kessler R.C., Almeida D.M., Berglund P., Stang P. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. Ann Allergy Asthma Immunol 2001, 87:289-295.
64. Vuurman E.F., van Veggel L.M., Uiterwijk M.M., Leutner D., O'Hanlon J.F. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993, 71:121-126.
65. Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol 2001, 108:S9-S15.
66. Simons F.E. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996, 17:185-189.
67. Flemons W.W., Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol 1997, 99:S750-S756.
68. Martin S.E., Engleman H.M., Deary I.J., Douglas N.J. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med 1996, 153:1328-1332.
69. Martin S.E., Wraith P.K., Deary I.J., Douglas N.J. The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med 1997, 155:1596-1601.
70. Juniper E.F., Guyatt G.H., Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994, 93:413-423.
71. Fisher L., Ghaffari G., Davies M., Craig T. Effects of poor sleep in allergic rhinitis. Curr Opin Allergy Clin Immunol 2005, 5:11-16.
72. Spaeth J., Klimek L., Mosges R. Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment. Allergy 1996, 51:893-906.
73. Kremer B., den Hartog H.M., Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy 2002, 32:1310-1315.
74. Juniper E.F., Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991, 21:77-83.
75. Juniper E.F., Ståhl E., Doty R.L., Simons F.E., Allen D.B., Howarth P.H. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 2005, 115:S390-S413.
76. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
77. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
78. Flemons W.W., Reimer M.A. Measurement properties of the calgary sleep apnea quality of life index. Am J Respir Crit Care Med 2002, 165:159-164.
79. Weaver T.E., Laizner A.M., Evans L.K., Maislin G., Chugh D.K., Lyon K., et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997, 20:835-843.
80. Mansfield L.E., Diaz G., Posey C.R., Flores-Neder J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol 2004, 92:240-244.
81. Craig T.J., Mende C., Hughes K., et al. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc 2003, 24:53-58.
82. Murray J.J., Nathan R.A., Bronsky E.A., et al. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc 2002, 23:391-398.
83. Golden S., Teets S.J., Lehman E.B., et al. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Ann Allergy Asthma Immunol 2000, 85:53-57.
84. McLean H.A., Urton A.M., Driver H.S., et al. Effect of treating severe nasal obstruction on the severity of obstructive sleep apnea. Eur Respir J 2005, 25:521-527.
85. Milgrom H., Biondi R., Georgitis J.W., et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol 1999, 83:105-111.
86. Goldbart A.D., Goldman J.L., Veling M.C., Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005, 172:364-370.
87. Ohta N, Sakuri S, Yoshitake H, et al. Study of the effects of anti-leukotriene receptor antagonists on chronic allergic rhinitis using QOL as an index. Presented at: World Allergy Congress; June 26-July 1; 2005; Munich, Germany.
88. Moinuddin R., deTineo M., Maleckar B., Naclerio R.M., Baroody F.M. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2004, 92:73-79.
89. Santos C.B., Hanks C., McCann J., Lehman E.B., Pratt E., Craig T.J. The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence. Allergy Asthma Proc 2008 Mar-Apr, 29(2):140-145.
90. van Cauwenberge P., Bachert C., Passalacqua G., Bousquet J., Canonica G.W., Durham S.R., et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000, 55:116-134.
91. Bousquet J., van Cauwenberge P., Khaltaev N. ARIA Workshop Group, World Health Organization: allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001, 108:S147-S334.
92. Gawchik S., Goldstein S., Prenner B., John A. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol 2003, 90:416-421.
93. Mandl M., Nolop K., Lutsky B.N. 194-079 Study Group: comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. Ann Allergy Asthma Immunol 1997, 79:370-378.
94. Meltzer EO, Staudinger H, Bloom M, et al. Efficacy of once-daily mometasone furoate in patients with seasonal allergic rhinitis and severe nasal congestion. Presented at: World Allergy Congress; June 26-July 1, 2005; Munich, Germany (abstract 710).
95. Bende M., Carrillo T., Vóna I., da Castel-Branco M.G., Arheden L. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol 2002, 88:617-623.
96. Wilson A.M., Orr L.C., Sims E.J., et al. Effects of monotherapy with intra-nasal corticosteroid or combined oral antihistamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001, 31:61-68.
97. Hughes K., Glass C., Ripchinski M., et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 2003, 58:380-385.
98. Craig T.J., Gurevich F., Glass C., et al. The effect of intranasal steroid budesonide on sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. J Allergy Clin Immunol 2004, 113:S332. (abstract 1227).
99. Kamenov S, Kamenov B, Moskovljevic J, et al. Intranasal budesonide treatment of rhino-sinusitis improves quality of life in school children. Presented at: World Allergy Congress; June 26-July 1, 2005; Munich, Germany.
100. Berlin J.M., Golden S.J., Teets S., Lehman E.B., Lucas T., Craig T.J. Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J Am Osteopath Assoc 2000, 100:8-13.
101. Mansfield L.E., Posey C.R. Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. Allergy Asthma Proc 2007 Mar-Apr, 28(2):226-229.
102. Bender B.G., Milgrom H. Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2004, 92:344-349.
103. Kiely J.L., Nolan P., McNicholas W.T. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax 2004, 59:50-55.
104. Potter P.C., Van Niekerk C.H., Schoeman H.S. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol 2003, 91:368-374.
105. Mintz M., Garcia J., Diener P., Liao Y., Dupclay L., Georges G. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol 2004, 92:255-261.
106. Craig T.J., Ferguson B.J., Krouse J.H. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol 2008 May-Jun, 29(3):209-217.